new ceo and chairman, page-8

Nothing new here in the new team.
Is Rooney associated with the new directors. Did he come on board when they did.
I can't see a takeover coming.
6 months for a new CEO - interesting.
Need to address funding next.
FDA is important but not the end. This is actually a tough trial, no doubt about it and rightly so - the mistake was not to be forthright about it in the first place - not informing the market of progress.
More trials are required and will cost money.
The last investor briefing was a vast improvement with much more information - stuff people have been asking for, for a long time.
It's a start but there is aways to go yet.